A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis Lawitz, E., Gane, E., Ruane, P., Herring, R., Younes, Z. H., Kwo, P., Zhang, J., Jia, C., Chuang, J., McColgan, B., Chung, C., Subramanian, M., Myers, R., Thali, R., Middleton, M., Li, K., Hellerstein, M., Noureddin, M., Harrison, S., Loomba, R. E M H SWISS MEDICAL PUBLISHERS LTD. 2019: 25S

View details for Web of Science ID 000531105300095